The growing population of older adults creates enormous demand for better diagnostics, therapies, assistive technologies and care-delivery solutions. The National Institute on Aging Small Business Program provides non-dilutive SBIR and STTR funding for U.S. startups developing products that improve healthy

Developing a cancer therapy, diagnostic or medical device can require years of expensive research before private investors are prepared to take the risk. The National Cancer Institute SBIR/STTR programme helps U.S. small businesses fund that early and translational development without

A biomedical startup can successfully complete an NIH Phase II project and still remain years away from commercial launch. The company may need specialist regulatory expertise, manufacturing development, clinical studies or validation work that falls outside the practical limits of

Many biomedical startups discover that proving an idea works is only the beginning. Clinical trials, regulatory studies, manufacturing scale-up and validation can require millions of dollars after a standard Phase II SBIR or STTR grant ends. The NIH SBIR Phase